1 in 1,000 individuals carry a germline mutation in the PKD1 or PKD2 gene, which leads to Autosomal Dominant Polycystic Kidney Disease (ADPKD). Cysts can form early in life and progressively increase in number and size during adulthood. Extensive research has led to the presumption that somatic inactivation of the remaining allele initiates the formation of cysts, and the progression is further accelerated by renal injury [1] [2] [3] [4] . However, this hypothesis is based primarily on animal studies in which the gene is inactivated simultaneously in large percentages of kidney cells. To mimic human ADPKD in mice more precisely, we reduced the percentage of Pkd1-deficient kidney cells down to 8 percent. Interestingly, no pathological changes occurred for six months after Pkd1 deletion, and additional renal injury increased the likelihood of cyst formation but never triggered rapid PKD. In mildly affected mice, cysts were not randomly distributed throughout the kidney but formed in clusters, which could be explained by increased PKD related signaling not only in cystic epithelial cells but also in healthy appearing tubules near cysts. In the majority of mice, these changes preceded a rapid and massive onset of severe PKD that was remarkably similar to human ADPKD. Our data suggest that initial cysts are the principal trigger for a "snowball" effect driving the formation of new cysts, leading to the progression of severe PKD. In addition, this approach is a suitable model for mimicking human ADPKD and can be used for pre-clinical testing.
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CHAPTER 5
Scattered deletion of Pkd1 in kidneys causes a cystic snowball effect and recapitulates Polycystic Kidney Disease ABSTRACT 1 in 1,000 individuals carry a germline mutation in the PKD1 or PKD2 gene, which leads to Autosomal Dominant Polycystic Kidney Disease (ADPKD). Cysts can form early in life and progressively increase in number and size during adulthood. Extensive research has led to the presumption that somatic inactivation of the remaining allele initiates the formation of cysts, and the progression is further accelerated by renal injury [1] [2] [3] [4] . However, this hypothesis is based primarily on animal studies in which the gene is inactivated simultaneously in large percentages of kidney cells. To mimic human ADPKD in mice more precisely, we reduced the percentage of Pkd1-deficient kidney cells down to 8 percent. Interestingly, no pathological changes occurred for six months after Pkd1 deletion, and additional renal injury increased the likelihood of cyst formation but never triggered rapid PKD. In mildly affected mice, cysts were not randomly distributed throughout the kidney but formed in clusters, which could be explained by increased PKD related signaling not only in cystic epithelial cells but also in healthy appearing tubules near cysts. In the majority of mice, these changes preceded a rapid and massive onset of severe PKD that was remarkably similar to human ADPKD. Our data suggest that initial cysts are the principal trigger for a "snowball" effect driving the formation of new cysts, leading to the progression of severe PKD. In addition, this approach is a suitable model for mimicking human ADPKD and can be used for pre-clinical testing.
INTRODUCTION
Individuals that carry a heterozygous mutation in PKD1 or PKD2 develop Autosomal Dominant Polycystic Kidney Disease (ADPKD). ADPKD is mainly characterized by focal cyst formation in the kidneys, leading to progressive enlargement of the kidneys, fibrosis of the remaining parenchyma and renal failure at middle-age 5 . The formation of cysts can already begin in utero, and new cysts can also form during adulthood 6;7 . Cysts form in a minority of nephrons, which suggests that a heterozygous mutation in PKD1 or PKD2 is not sufficient to induce cyst formation. Evidence suggests that for cyst formation to occur, it is required that during life also the second allele is lost by for instance a somatic mutation. Indeed, epithelial cells isolated from individual cysts are clonal in origin and frequently have lost the remaining normal allele by a somatic mutation 1 . In mice, although homozygous inactivation of Pkd1 or Pkd2 leads to cyst formation and embryonic lethality, heterozygous knock-out (KO) mice have no overt phenotype 8 . Moreover, mice carrying a combination of one Pkd2-null and one unstable Pkd2-WS25 allele develop renal cysts 9 . The window of Pkd1 expression must be regulated rather tightly, as models with reduced (down to <20%) or elevated (by 2-15 fold) Pkd1 levels also develop PKD [10] [11] [12] [13] .
To circumvent embryonic lethality, Pkd1 conditional knock-out mice have been generated in which Pkd1 or Pkd2 are inactivated. These mice develop PKD and revealed that the context of renal tissue has a profound impact on the rate of disease progression. Deletion of Pkd1 prior to post-natal day 13 (PN13) results in rapid disease onset, whereas deleting Pkd1 in adult mice results in a much slower progression 14;15 . Kidneys from these adult mice only exhibit mild pathological changes such as tubular dilations during the first 2-3 months after Pkd1 knock-out, after which the disease progresses to end-stage renal failure due to massive enlargement of the kidneys 14 . The disease progression accelerates considerably following acute renal injury, which led to the view that renal injury is an important trigger for cyst formation in the adult kidney [2] [3] [4] . However, this view is primarily based on studies with adult mice in which Pkd1 is deleted in much larger proportions of cells than in human ADPKD patients. To mimic human ADPKD more precisely, we therefore reduced the number of Pkd1-deficient kidney cells in tamoxifen-inducible kidney-specific Pkd1-deletion (iKspPkd1 del ) mice down to 8 percent 14 . The data reveal that scattered-Pkd1-deletion leads to a long dormant period followed by a relatively rapid onset of severe PKD in the majority of mice. Our data suggest that this sudden shift was primarily caused by the initial cysts that triggered a "cystic snowball" effect driving the formation of new cysts. In addition, our approach is a suitable model for mimicking human ADPKD and will provide more accurate predictions of clinical outcome.
RESULTS
Scattered-Pkd1-deletion in 8% of kidney cells in mice does not lead to PKD within 6 months
We previously developed a conditional knock-out mouse model (iKsp-Pkd1 del ) in which high-dose (5 mg) tamoxifen administration at post-natal day (PN) 40 leads to Cre-mediated conversion of Pkd1 lox to Pkd1 del alleles in >40 % of the kidney cells and to severe PKD within 4-5 months (Figure 1 To mimic human ADPKD more precisely, we treated iKsp-Pkd1 lox,lox mice with a range of tamoxifen doses and quantified the number of Pkd1-deficient cells by using extensionmultiplex ligation-dependent probe amplification (eMLPA) ( Figure S1 ) 17 . Mice treated with 2.5 mg tamoxifen developed a moderate cystic phenotype accompanied by increased kidney to bodyweight ratios (2KW/BW), and reducing the dose further did not lead to cystogenesis (Figure 1, A-B) . However, even at the lowest dose tested (0.25 mg), 5-10% of the Pkd1 lox DNA had been converted to Pkd1 del DNA ( Figure 1C ). Six months after receiving low-dose (i.e. 0.25 mg) tamoxifen treatment, there was no indication of cyst formation in the analyzed sections ( Figure 2A ). In addition, besides a few clearly dilated tubules (3 out of 1311), the tubular diameters were still unaltered ( Figure 2B ). We confirmed homozygous inactivation of Pkd1 using eMLPA, since regardless of the tamoxifen dose, iKsp-Pkd1 lox,lox mice contain twice as much Pkd1 del DNA as iKsp-Pkd1 lox,wt mice ( Figure 2C ). In addition, low-dose tamoxifen treatment of iKsp-Pkd1 del,lox mice resulted in recombination of the remaining functional Pkd1 lox allele ( Figure 2D and S1). Six months following low-dose tamoxifen treatment, these iKsp-Pkd1 del,lox mice, carrying the homozygous Pkd1 deletion, also lacked a cystic phenotype ( Figure S2 ). To visually determine the location of the Pkd1-deficient cells, we crossbred iKsp-Pkd1 lox,lox mice with LacZ reporter (R26R) mice 19 . High-dose tamoxifen resulted in wide-spread Cre activation and the development of severe PKD four months after treatment ( Figure 2E ). In contrast, low-dose-treated mice had a mosaic pattern of Pkd1-deficient cells, and this pattern was stable over time; again, these mice displayed no overt pathological changes, even after six months ( Figure 2E and S3).
Renal injury following scattered-Pkd1-deletion is insufficient to induce rapid PKD
Renal injury has been shown to accelerate PKD progression in several animal models for PKD 2-4;20 . Injury-induced tubular epithelial cell proliferation due to treatment with the nephrotoxic compound 1,2-dichlorovinyl-cysteine (DCVC) accelerates PKD in high-dose tamoxifen-treated iKsp-Pkd1 del,lox mice 3 . In addition, hypertrophic responses to reduced renal mass following unilateral nephrectomy can have similar effects in ift88 mice 20 . Here, we found that unilateral nephrectomy also accelerated PKD in high-dose tamoxifen-treated iKsp-Pkd1 lox,lox mice ( Figure S4 ). Based on these findings, we asked whether renal injury is required to initiate cyst formation in low-dose-treated mice. Surprisingly, although the prevalence of cyst formation was higher in mice that underwent nephrectomy and/or DCVC injections, the analyzed renal sections of 57% of in total 51 low-dose-treated mice with renal injury had no cysts 4-6 months after the procedure ( Figure 3A and 3B). Even the most severely affected mice only developed few clusters of cysts while most of the renal parenchyma appeared normal, indicating that the vast majority of Pkd1-deficient cells had not been triggered to form cysts under these conditions ( Figure 3C ). The prevalence of cyst formation was higher-albeit still relatively rare-on a Pkd1 . Thus, within a period of 6 months following scattered-Pkd1-deletion, the adult kidney remains largely resistant to cyst formation even after renal injury. A long dormant period is followed by a phenotypic switch towards a rapid onset of severe PKD Since scattered-Pkd1-deletion with or without renal injury did not lead to severe PKD within the first six months, we followed a number of these mice further in time. Strikingly, the 2KW/BW% more than doubled (2-6 fold) in 13 out of 17 mice euthanized at age 47-57 weeks and correlated with increased cystic index and a decline in renal function ( Figure 4 , A-D and S5). Segment-specific marker staining revealed cysts derived from the proximal and distal region of the nephron and-to a lesser extent-in the collecting duct ( Figure S6 ). Compared to the mice without DCVC treatment, the mice with DCVC treatment tended to develop PKD slightly sooner ( Figure 4D ). Although this difference was not statistically significant, the trend is consistent with the increased prevalence of cysts due to renal injury in the mice that had been euthanized 4-6 months following scattered-Pkd1-deletion ( Figure 3B ). To further confirm the delayed onset of severe PKD, we performed MRI analysis on two low-dose tamoxifen treated iKsp-Pkd1 lox,lox mice (also shown in figure 4D ). Again, the vast majority of cysts only appeared in the later stages of PKD progression, whereas in the first 32 weeks following scattered-Pkd1-deletion only some cysts were formed ( Figure 4E and S8A). Collectively, these data suggest that following a long dormant period, additional factors can trigger a sudden shift from low-frequency to high-frequency cyst formation. (a) Images of a typical polycystic kidney ten months after Pkd1 deletion (by low-dose tamoxifen treatment) and an age-matched wild-type control kidney. Scale bar, 5mm (b) H&E-stained kidney section from a severely affected mouse (Blood Urea (BU), 51.2 mmol/L) ten months after low-dose tamoxifen treatment. Scale bar, 2mm (c) H&E-stained kidney section from a moderate-severely affected mouse (BU, 22 mmol/L) with focal clustered cyst formation. Note the many small cysts around the larger cysts (examples indicated by arrowheads). Scale bar, 500 µm (d) The ratio of the combined kidney weight to the total body weight was calculated as a percentage (2KW/ BW) and plotted against age for iKsp-Pkd1 del,lox mice that were treated with low-dose tamoxifen with or without DCVC treatment. Two iKsp-Pkd1 lox,lox mice that were followed by MRI analysis (see figure 4E and S8A) were also included in the graph. The time of the low-dose tamoxifen treatment is indicated by the arrow (Pkd1-cKO figure 4D ) and BU of 23.4 mmol/L.
The switch towards a rapid onset of severe PKD is not caused by aging or increased proliferation
We investigated whether the sudden shift from low-frequency to high-frequency cyst formation was triggered by possible altered kidney homeostasis due to general aging. However, aged mice (up to an age of 388 days (PN388)) that received low-dose tamoxifen and nephrectomy did not develop severe PKD within five months ( Figure 5A ), excluding the possibility that the severe onset of PKD was caused by age-related events. In addition, we confirmed once more that these mice developed severe PKD following a long dormant period ( Figure 5A and S7).
A plethora of studies have described complex networks of signaling pathways that-without Polycystin-1-leads to increased cell proliferation, which may be one of the factors that drive cyst formation 22 . We tested whether proliferation was increased prior to the onset of severe PKD by analyzing the occurrence of cells that were positive for Ki-67, a marker of proliferation. However, already one to two months following scattered-Pkd1-deletion, the mice had a modest increase in proliferation, and this increase was stable over time, indicating that the change in proliferation was not restricted to the period just prior to the onset of severe PKD ( Figure 5 , B and C). In addition, we analyzed apoptosis by Caspase-3 staining but found only few apoptotic cells per renal section, which was too low to be correlated with the proliferation index (not shown). However, the pattern of Pkd1-deficient cells remained stable over time ( Figure S3 ). These data suggest that scattered-Pkd1-deletion rapidly triggers a modest increase in proliferation, which does not immediately affect the tubular architecture. 
Evidence for a 'cystic-snowball' effect
Following scattered-Pkd1-deletion, the cysts tended to grow in clusters, rather than being equidistantly scattered ( Figure 3C , 4C, 4E, S8A, S8B). These clusters only appeared in the last 10-12 weeks of the disease, long after the tamoxifen treatment ( Figure 4E , S8A). Although we cannot exclude that cysts from some clusters originated simultaneously from regions with more closely packed Pkd1-deficient cells, the location of small cysts and dilated tubules near larger cysts ( Figure 3C , 4C, S6, S8A, S8B) suggests that the initiation of the cysts within clusters occurred at different moments.
To determine if the distribution of cysts indeed followed a clustered pattern rather than a random pattern, we applied the nearest-neighbor analysis on seven mildly affected mice that were euthanized 4-6 months following scattered-Pkd1-deletion and renal injury (from the analysis in figure 3B ). The distances of each cyst with its nearest neighboring cyst were plotted in a cumulative frequency plot, and compared to a similar type of cumulative frequency plot that was generated from twenty simulations of an equal number of randomly distributed points within an equally sized area. One mouse did not show a statistical significant clustering, which is likely explained by the low number of cysts in that mouse ( Figure S8C ). The other six mice displayed a distribution of cysts typical for a clustered pattern ( Figure 6A and S8C). We hypothesized that preferential cyst formation near existing cysts, is driven by PKDrelated signaling pathways that are locally and persistently activated in surrounding tissue near cysts. Therefore, we performed immunohistochemistry to analyze phospho-STAT3, phospho-CREB, phospho-AKT, phospho-ERK1/2 and LCN2 expression, which have been shown to be involved in PKD 18;23-33 . The clustered distribution of cysts in a iKsp-Pkd1 del,lox mouse that was treated with low-dose tamoxifen, unilateral nephrectomy and DCVC, and euthanized six months after tamoxifen treatment (clustering is shown in figure 6A ) indeed co-occurred with increased expression of these proteins specifically near cysts or clusters of cysts ( Figure 6B ). We quantified the number of cysts/clusters that showed this effect in renal sections at two different locations in the kidneys of seven other mildly affected mice. Although regions around smaller and isolated cysts often did not show increased expression of these proteins, in total, the expression around 31-62% of cysts was clearly elevated ( Figure 6C ). Collectively, our data suggest the following model: The likelihood of cyst formation upon PKD1-KO is low but sufficient to induce cyst formation at low-frequency. The frequency of cyst formation is increased by acute renal injury but remains low. However, the persistent stress imposed by initial cysts on surrounding tissue, triggers a snowball effect in which local aberrant PKD-related signaling increases the likelihood of new cyst formation, which ultimately leads to accelerated progression towards end-stage PKD (Figure 7 ). Figure 3C ). The graph depicts two plots. One is a cumulative plot generated from measurements of distances between nearest neighboring cysts (distances cysts), and one is an average of twenty simulations of similar types of cumulative plots but then of nearest distances of an equal number of points that were randomly distributed over an equally sized area (distances random). Horizontal error bars indicate 2x the standard deviations (2sd) of the random simulations.
Note that the plot of the measured distances between nearest neighboring cysts is located at the left of the random simulations, indicating a relatively high number of short distances typical for a clustered distribution. (t; x-axis) increases the probability (P; y-axis) of cystogenesis, cystogenesis is rare. Even when the adult kidney is challenged by renal injury, which further increases the probability, cyst formation occurs only incidentally (lowfrequency cyst formation). However, the initial cysts impose continuous stress onto surrounding tissue, which locally increases the probability and frequency of new cyst formation, leading to a snow-ball effect (high-frequency cyst formation). As time proceeds, larger regions of the kidney become increasingly susceptible for cyst formation, which ultimately leads to severe PKD.
DISCUSSION
In animal models of PKD and in ADPKD patients, the rate of cyst growth is much faster during development than during adulthood 6;14;15 . However, given the many microscopic cysts that have been detected in kidneys of adult ADPKD patients, it is likely that new cysts also form during adulthood 7 . In patients, the time-interval between the moment a cell loses functional Polycystin signaling and the moment at which this cell starts to form a cyst, is not known. In this study, we reduced the percentage of Pkd1-deficient cells in adult mouse kidneys down to 8 %, which surprisingly did not lead to a PKD phenotype within 6 months, suggesting that this time-interval can be much longer than is expected from previous data 14 . We and others have found that the relatively slow progression of cyst growth in adult animal models is accelerated by additional renal injury, which suggests that renal injury is an important trigger for cyst formation in the adult kidney 2-4;20 . It is likely that a combination of several processes, i.e. cell death, proliferation, epithelial dedifferentiation, altered planar cell polarity and inflammation, underlie the injury induced acceleration of cystogenesis 3;34 . Although several types of renal injuries in mice with scattered-Pkd1-deletion led to increased likelihood of cyst formation ( Figure 3B ) these injuries never triggered a rapid disease onset and most of the renal parenchyma remained normal. The lack of a rapid disease onset following renal injury in our scattered-Pkd1-deletion model therefore differs from previous data. Two explanations might underlie this difference: 1) Since the number of Pkd1-deficient cells is lower than in other studies, it is less likely that cells are subjected to both loss of Pkd1 and injury. 2) Despite a low number of renal epithelial cells without functional Pkd1, the majority of cells with functional Pkd1 are able to maintain tubular architecture, even during short pulses of tubular injury. Either way, scattered-Pkd1-deletion led to a low frequency of cyst formation, which was slightly increased by renal injury. Following this dormant period with low-frequency cyst formation, the majority of mice rapidly developed severe PKD. We excluded the possibility that this shift towards more susceptibility for cyst formation is triggered by advanced age or progressive changes in proliferation rates over time ( Figure 5 ). It has been shown before that the presence of cysts affects neighboring non-cystic tubules, which then become obstructed and have increased proliferation and apoptosis [35] [36] [37] . We hypothesized that the initial cysts may cause a snowball effect by triggering resident Pkd1-deficient cells in neighboring tubules to form new cysts. If our presumption is true, this would implicate that 1) the continuous stress by cysts on their surroundings leads to altered signaling in tubules near cysts, 2) cysts generally form in clusters and 3) the progression is faster at an advanced stage. Our data show that although the mosaic pattern of Cre activation occurred everywhere throughout the kidney, as shown by crossbreeding experiments with LacZ reporter mice, some areas were clearly cystic whereas other regions were virtually unaffected. We cannot exclude that some clusters of cysts originated from regions with more closely concentrated Pkd1-deficient cells, possibly due to uneven distribution of tamoxifen.
However, from our histological data it seems unlikely that small dilated tubules just over 50 µm were formed simultaneously with cysts having diameters of over 1000 µm. Longitudinal MRI analysis further demonstrated that the number of cysts particularly increased in the last 10-12 weeks of disease progression and that these cysts were formed near existing isolated cysts that were visible at 32 weeks following scattered-Pkd1-deletion ( Figure 4E,  S8A ). Collectively these data suggest that existing cysts locally confer susceptibility for new cyst formation in their vicinity. If true, it is expected that molecular changes underlie the local increased susceptibility near existing cysts. A number of mildly affected mice with scattered-Pkd1-deletion, which had few cysts and were sacrificed prior to the onset of severe PKD, allowed us to test this hypothesis. We compared the expression of a number of PKD related proteins between 'cystic' and 'non-cystic' regions. Phosphorylated STAT3 (pSTAT3) has been shown to be elevated in PKD and its inhibition alleviated cyst formation in mice 18;23;24 . LCN2, a marker for renal injury and highly expressed in cystic kidneys, is likely also involved in cystic growth since crossbreeding of juvenile cystic kidney (jck) mice with Lcn2 KO mice, reduced cystic growth [25] [26] [27] . Also activation of AKT and ERK1/2 has been associated with cystic disease and analysis of phosphorylated CREB has been used before as a read-out for cAMP, an important 2 nd messenger involved in PKD [28] [29] [30] [31] [32] [33] . In addition, Ki-67 expression was analyzed as a marker for proliferation. Indeed, the expression of these proteins was frequently elevated in tissue near cysts compared to tissue more distant to cysts. Also dilated tubules and small cysts that preferentially located near larger cysts had increased PKD-related signaling ( Figure 6 ). Smaller isolated cysts generally did not show altered signaling in their vicinity, but we cannot rule out that as small cysts increase in size over time, similar effects will take place. Collectively, scattered-Pkd1-deletion leads to a phenotype that differs considerably from previously reported mouse models with high-percentages of Pkd1-deficient cells, in which all renal tubules slowly but progressively dilate after Pkd1 inactivation, leading to massively enlarged kidneys. The model presented here, provides evidence for the existence of a cystic-snowball effect, in which the first cysts pose continuous stress onto surrounding tissue, resulting in aberrant PKD-related signaling. Over time this will dramatically increase the likelihood of new cyst formation, leading to accelerated cystogenesis and severe PKD (Figure 7) . The stochastic nature of this process is inherently associated with large variability. Although this may complicate pre-clinical testing, the phenotype in these mice is remarkably similar to the phenotype in human ADPKD patients. Data from the Consortium of Radiologic Imaging Studies (CRISP) showed that although cysts may form at different ages and grow at different rates, Total Kidney Volume (TKV) follows an exponential growth curve 38;39 . The number of cysts and the growth-rate can vary between patients, giving rise to large but predictable inter-patient variability. The variation in the mice shown in figure 4D , might reflect a similar pattern. The cystic-snowball effect implies that the number of initial cysts is important since these cysts will ultimately trigger the formation of many more cysts, giving rise to multiple clusters of growing cysts. Therefore, variation in the initial number of cysts might result in different TKV growth rates, giving rise to the pattern of data-points in figure 4D . In addition, mice that also had been treated with DCVC tended to have increased kidney weights earlier than the mice without additional DCVC treatment, which might be a reflection of the higher prevalence of initial cysts that were observed in injured mice that were euthanized 4-6 months following scattered-Pkd1-deletion ( Figure 3B ). To date, pre-clinical models have been invaluable in identifying many important signaling cascades that were then targeted in a number of clinical trials [40] [41] [42] [43] . However, to predict the outcome of a therapeutic approach with higher precision, the model must mimic human ADPKD as closely as possible. Our study demonstrates that this can be achieved by reducing the number of adult Pkd1-deficient cells in the kidneys, and this strategy can likely be applied to other rodent models that use conditional Pkd1 or Pkd2 inactivation. These models will therefore help guide the development and refinement of improved therapeutic strategies and will provide more accurate predictions of clinical outcome.
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CONCISE METHODS
Mice and treatments
Inducible kidney-specific Pkd1-deletion mice (iKsp-Pkd1 del ) were either on a Pkd1 del,lox , Pkd1 lox,lox , or Pkd1 lox,wt background 14 . The Pkd1 lox allele has Lox-P sites flanking exon 2-11, and this region is deleted in the Pkd1 del allele. A number of mice were also crossbred with LacZ reporter (R26R) mice 19 . Only male mice were used in all experiments. Oral tamoxifen administration (High-dose; 5 mg, Low-dose; 0.25 mg) was performed as previously described on three consecutive days at post-natal (PN) days 40-42, unless otherwise indicated 16 . 1,2-dichlorovinyl-cysteine (DCVC) administration consisted of a single intra-peritoneal injection of 15 mg/kg as described previously 3 . For unilateral nephrectomy mice were anesthetized with 4 % isoflurane and maintained at 1.5-2 %. Following a small incision in the right lumbar region, the renal hilum of the right kidney was tied off and then the kidney was removed and the wound was closed. A group of mice underwent a sham-operation; these mice underwent the same procedure but kidneys were left undisturbed. The first renal injury procedure was carried out 6-10 days after the tamoxifen administration. In mice with two renal injuries, the second procedure was always carried out within 5 weeks after tamoxifen administration. Blood sampling and blood urea (BU) measurements were performed using Reflotron technology (Kerkhof Medical Service) as described previously 3 . All mice were on a full C57BL/6 genetic background. The local animal experimental committee of the Leiden University Medical Center and the Commission Biotechnology in Animals of the Dutch Ministry of Agriculture approved the experiments performed.
(Immuno)-histochemical analysis
Renal sections (4 µm) were prepared from paraffin embedded kidneys that had been fixed in buffered 4 % formaldehyde solution and stained with hematoxylin and eosin (HE) using standard procedures. The tubular diameters were measured using the Panoramic Viewer 1.15 software from 3DHistech Ltd. by drawing a line perpendicular to the basal membranes of two opposite nuclei of randomly chosen tubules throughout the cortex. The cystic index was measured from total scans from H&E-stained kidney sections as the percentage of cystic area relative to total tissue as determined by Image J software (public domain software, National Institutes of Health). Prior to the measurements, signal from protein casts within cysts that might influence the measurements was removed using Photoshop software. The quantification of the number of cysts (defined as larger than three glomeruli) in figure 3 was done by an investigator who was blinded to the treatment.
For X-gal blue staining 3 mm sections from frozen kidneys were cut manually with a scalpel and fixed twice for 20 minutes in 0.2 % glutaraldehyde, 1.5 % formaldehyde, 2 mM MgCl 2 , 5 mM EGTA and 100 mM sodium phosphate pH 7.3. The sections were washed three times in 2 mM MgCl 2 and 100 mM sodium phosphate pH 7.3 and stained O/N (in the dark at room temperature) in X-gal staining solution (5 mM K 3 Fe(CN) 6 , 5 mM K 4 Fe(CN) 6 , 1 mg/ml X-gal, 2 mM MgCl 2 and 100 mM sodium phosphate pH 7.3). Following post-fixation in buffered 4 % formaldehyde solution and paraffin embedding, the thick sections were further cut into 4 µm thick sections. The first few sections could be used and were counterstained with Nuclear Fast Red solution. For each time-point after tamoxifen administration 2-3 mice were stained for LacZ activity. For immunohistochemical analysis, sections were deparaffinized and subjected to heatmediated antigen retrieval (10 mM/1 mM Tris/EDTA, pH 9.0 for anti-phospho-Stat3 (Tyr705) (Cell Signaling, no. 9145) and LCN2 (R&D systems no. AF1857); 10 mM citrate buffer pH 6.0 for rabbit anti-Ki-67 (Bio Connect Services, no. NCL-Ki67p), anti-phospho-Akt (Ser473), anti-phospho-ERK1/2 (Thr202/204), anti-phospho-CREB (Ser133), and anti-cleaved Caspase 3 from Cell Signaling Technologies (no. 4060, 4370, 9198 and 9661 respectively). Sections were blocked with 0.1% H 2 O 2 for 20 min. for endogenous peroxidase activity and preincubated for 1 h with 5% normal goat serum in 1% BSA in PBS. Next, the sections were incubated O/N with anti-pSTAT3 (1:75), anti-LCN2 (1:150), anti-Ki-67 (1:3,000), rabbit antimegalin(gp330) (1:500; Pathology LUMC, Leiden, the Netherlands), goat anti-Tamm Horsfall protein (uromodulin,1:4000; Organon Teknika-Cappel), rabbit anti-aquaporin-2 (1:4,000; Calbiochem, no. 178612), anti-pAkt (1:50), anti-pERK1/2 (1:400), anti-pCREB (1:800) or antiCaspase 3 (1:300) in 1% BSA in PBS. Following incubation with rabbit Envision horseradish peroxidase (Dako, no. K4011) or rabbit-anti-goat HRP (1:100, Dako, no. P0449), immune reactions were revealed using diaminobenzidine as a chromogen and counterstained with hematoxylin, dehydrated, and mounted. To determine PKD-related signaling in and around cysts two or three sections at different locations within the kidney were used per staining.
The nearest-neighbor analysis
The nearest neighbor analysis as applied here is a modification of the method described by Clark PJ. et al. 44 Relative distances of each cyst with its nearest neighboring cyst within a kidney section were measured using Photoshop software. For each analysis twenty random simulations of an equal number of points in an equally sized rectangle (this size is equal to the size of the cortical region of the section in which cysts can be expected) were generated using Excel software, and the nearest distances of each point to its nearest neighboring point were calculated using Excel software. Each graph depicts two cumulative plots. One that has been generated from the actual measured distances of the cysts and their nearest neighboring cysts, and one that has been generated from the averages of the cumulative plots of the randomly simulated nearest distances. The error bars indicate 2x the standard deviations (2sd) of the twenty simulations. Cumulative plots of measured distances that are located at the left of the plot of the random simulations, indicate a relatively high number of short distances between the cysts, typical for a clustered distribution. When the plot of the measured distances is also located outside of the region within 2sd's of the random simulations, the distribution in considered to be clustered and not random. Sections with 5 or more cysts from different regions of the kidneys from seven mildly affected mice (from the analysis of figure 3B ) were used to perform the analysis, and the analysis of one section per animal is shown in figure 6A and S8C.
Extension-multiplex ligation-dependent probe amplification (eMLPA)
The position of the probes used for hybridization to DNA isolated from kidneys is outlined in figure S1 and described previously 17 . DNA was isolated using Nucleobond AXG 100 columns according to manufacturer's protocol (Macherey-Nagel, no. 740545). Following a denaturing step of the DNA (5 min. at 95 °C), hybridization was carried out for 4 hours at 60 °C in 5 µl containing MLPA buffer (MRC-Holland), 4 nM of each probe and 250 ng of the denatured DNA. Extension and ligation reactions were performed simultaneously for 15 minutes at 54 ºC by adding 40 µl of pre-warmed solution containing 2 mM dNTP's, 1 U Stoffel Taq polymerase (Applied Biosystems), 3 µl Buffer A, 3 µl buffer B and 1 µl Ligase-65 (MRC-Holland). Following 5 minutes at 95 ºC to inactivate the ligase, 5 µl of each sample was used in a 25 µl PCR reaction with 31 rounds of amplification. Samples were run on a 3730 DNA analyzer and relative peak-ratios were used to determine Cre-mediated recombination efficiency (Peak Scanner v1.0 software, Applied Biosystems). Each hybridization was carried out at least four times and for each experiment eight Pkd1 del,lox samples were included from which the median of the obtained peak-ratios served as a 50 % Pkd1 del DNA reference.
Proliferation index
Sections were stained with anti-Ki-67 as described above to visualize proliferating cells. Six images (100*) throughout the cortex from one renal section per mouse were taken. Counting was carried out by an investigator who was blinded to the treatment. The total number of nuclei were counted using free available image-J software and Ki-67 positive nuclei were counted manually. The ratio of Ki-67 positive nuclei to the total number of nuclei was calculated as a percentage.
MRI analysis
MRI measurements were performed with a 7 T Bruker Pharmascan Biospin (Burker, Ettingen, Germany). Mice were anesthetized with 3 % isoflurane and maintained at 1.5-2 %. The mice were imaged with a RARE imaging sequence (TR = 11.21 ms, effective TE = 44.84 ms). A sufficient number of slices were imaged with a slice thickness of 0.35 mm, a matrix size of 300 x 300 and field of view of 3 x 3 cm. Respiratory triggering was used to minimize motion artifacts due to breathing. Two low-dose tamoxifen treated iKsp-Pkd1 lox,lox were imaged at the indicated time-points ( Figure 4E, S8 ).
Statistical analysis
Differences in Pkd1
del DNA content in iKsp-Pkd1 lox,lox versus iKsp-Pkd1 lox,wt mice were tested using two-tailed Student's t-tests. The Difference in onset of renal failure between nephrectomized and sham operated mice that received high-dose (5 mg) tamoxifen was tested with the generalized Wilcoxon test. Comparison of the prevalence of cyst formation between mice that underwent renal injury or not, was tested with Mann-Witney U tests. Differences in proliferation indices were tested with two-tailed Student's t-tests.
SUPPLEMENTAL DATA
Supplemental Figure 1 . Extension-multiplex ligation-dependent probe amplification (eMLPA) strategy used to quantify Cre-mediated recombination efficiency 1 . Probes with universal end-sequences that are used for amplification are hybridized onto the target DNA as indicated. After an extension step of the forward probe using Stoffel-Taq polymerase to fill the gaps between the probes, a ligation step finalizes the templates for PCR. In a PCR reaction using a single primer pair, of which the forward primer is fluorescently labeled, all products are simultaneously amplified. The products are separated and visualized with a capillary sequencer. The relative peakheights are used to quantify the Cre-mediated recombination efficiency. 
